Bashir Amani A, El-Zaheri Mohamed M, Bashir Ahmad A, Fayyad Luma, Obed Aiman H, Alkam Dima, Bashir Abdalla Y
Department of Pathology, University of Iowa Hospitals & Clinics, Iowa City, IA 52246, USA.
Department of Endocrinology, Ibn Sina University for Medical Sciences & Jordan Hospital, Amman 11152, Jordan.
Cancers (Basel). 2025 Jun 18;17(12):2029. doi: 10.3390/cancers17122029.
BACKGROUND/OBJECTIVES: With evolving guidelines favoring de-escalation in the management of papillary thyroid microcarcinoma (PTMC), options such as active surveillance and minimally invasive procedures are now considered for patients with low-risk disease. However, a subset of PTMCs-particularly non-incidental cases-may exhibit aggressive behavior. This study compares disease characteristics and outcomes between incidental and non-incidental PTMCs over a 10-year period.
This is a single-center retrospective comparative analysis utilizing a prospectively collected database of patients referred for thyroid surgery.
Papillary thyroid carcinoma accounted for 86.7% of thyroid malignancies, with PTMC comprising 36.2% (137 patients). Incidental PTMC represented 109 out of 1012 patients undergoing surgery for benign thyroid disease (10.8%). Non-incidental PTMC (NIPTMC), diagnosed preoperatively and presenting clinically without coexisting thyroid disease, was identified in 28 patients (20.4%). NIPTMCs were more frequently associated with high-risk features (75% vs. 10.1%, = 0.004), including extrathyroidal extension (21.43% vs. 7.3% = 0.0015), positive central lymph nodes (21.43% vs. 2.8%, = 0.0291), positive lateral lymph nodes (28.6% vs. 0% = 0.012), and lymphovascular invasion (3.6% vs. 0%). Multifocal PTMC was seen in 37 patients (27%), of which 27 had bilobar disease. Multifocal tumors had a higher likelihood of high-risk features (48.6% vs. 14%, = 0.007). NIPTMC was a significant predictor of multifocality ( = 0.0098). All patients underwent surgery, none opted for active surveillance. NIPTMC is more often associated with high-risk features and multifocality, necessitating more extensive surgery. These findings emphasize the need for careful preoperative risk stratification to guide individualized management.
背景/目的:随着甲状腺微小乳头状癌(PTMC)管理中倾向于降阶梯治疗的指南不断发展,对于低风险疾病患者,现在会考虑诸如主动监测和微创手术等选择。然而,一部分PTMC,尤其是非偶发病例,可能表现出侵袭性。本研究比较了10年间偶发和非偶发PTMC的疾病特征和结局。
这是一项单中心回顾性比较分析,利用前瞻性收集的甲状腺手术转诊患者数据库。
甲状腺乳头状癌占甲状腺恶性肿瘤的86.7%,其中PTMC占36.2%(137例患者)。偶发PTMC占1012例接受良性甲状腺疾病手术患者中的109例(10.8%)。在28例患者(20.4%)中发现了术前诊断且临床上无并存甲状腺疾病的非偶发PTMC(NIPTMC)。NIPTMC更常与高风险特征相关(75%对10.1%,P = 0.004),包括甲状腺外侵犯(21.43%对7.3%,P = 0.0015)、中央淋巴结阳性(21.43%对2.8%,P = 0.0291)、侧方淋巴结阳性(28.6%对0%,P = 0.012)和脉管侵犯(3.6%对0%)。37例患者(27%)出现多灶性PTMC,其中27例为双侧病变。多灶性肿瘤具有高风险特征的可能性更高(48.6%对14%,P = 0.007)。NIPTMC是多灶性的重要预测因素(P = 0.0098)。所有患者均接受了手术,无人选择主动监测。NIPTMC更常与高风险特征和多灶性相关,需要更广泛的手术。这些发现强调了术前仔细进行风险分层以指导个体化管理的必要性。